Metal-Based Drugs

Metal-Based Drugs / 1994 / Article

Open Access

Volume 1 |Article ID 237030 | https://doi.org/10.1155/MBD.1994.291a

Carmen Socaciu, Ioan Pasca, Cristian Silvestru, Adela Bara, Ionel Haiduc, "Antitumor Organometallics. IV. The Mutagenic Potential of Some Diphenylantimony(III) Dithiophosphorus Derivatives", Metal-Based Drugs, vol. 1, Article ID 237030, 7 pages, 1994. https://doi.org/10.1155/MBD.1994.291a

Antitumor Organometallics. IV. The Mutagenic Potential of Some Diphenylantimony(III) Dithiophosphorus Derivatives

Received27 Oct 1993
Accepted10 Jan 1994

Abstract

Two diphenylantimony(III) derivatives of dithiophosphorus ligands, i.e. Ph2SbS2PPh2 and Ph2SbS2P(OPr-i)2, which were previously found to exhibit antitumor properties, have been now investigated for potential mutagenic effects in healthy and Ehrlich ascites tumor-bearing mice. Two short-term tests, i.e. the micronucleus test and the cytogenetic analysis, were used as end-points for mutagenicity. The results are consistent with a mutagenic potential for both organoantimony(III) compounds tested, the effect being higher for the phosphorodithioato derivative.

Copyright © 1994 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views69
Downloads15
Citations